HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alain Morère Selected Research

Mannose (D-Mannose)

7/2020The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics.
10/2019Porphyrin-based bridged silsesquioxane nanoparticles for targeted two-photon photodynamic therapy of zebrafish xenografted with human tumor.
6/2019Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.
1/2019Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease.
10/2018Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.
11/2016Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe Disease.
2/2016Ruthenium(ii) complex-photosensitized multifunctionalized porous silicon nanoparticles for two-photon near-infrared light responsive imaging and photodynamic cancer therapy.
5/2015Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.
12/2014Two-photon excitation of porphyrin-functionalized porous silicon nanoparticles for photodynamic therapy.
11/2011Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alain Morère Research Topics

Disease

7Neoplasms (Cancer)
07/2020 - 11/2011
5Breast Neoplasms (Breast Cancer)
10/2019 - 03/2009
3Prostatic Neoplasms (Prostate Cancer)
06/2019 - 05/2015
3Glycogen Storage Disease Type II (Pompe's Disease)
01/2019 - 11/2016
1Rhabdomyosarcoma
07/2020
1Muscular Diseases (Myopathy)
11/2016
1Rare Diseases (Rare Disease)
08/2012
1Retinoblastoma (Glioblastoma, Retinal)
08/2012
1Colorectal Neoplasms (Colorectal Cancer)
02/2012
1Metrorrhagia (Spotting)
03/2011
1Phototoxic Dermatitis (Phototoxicity)
12/2010
1Cicatrix (Scar)
05/2006
1Carcinoma (Carcinomatosis)
10/2003

Drug/Important Bio-Agent (IBA)

13Mannose (D-Mannose)IBA
07/2020 - 05/2006
91-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2020 - 03/2009
4Silicon Dioxide (Silica)FDA LinkGeneric
06/2019 - 11/2011
4EnzymesIBA
01/2019 - 05/2006
3PorphyrinsIBA
07/2020 - 10/2017
3Photosensitizing Agents (Photosensitizers)IBA
10/2017 - 02/2012
2CationsIBA
06/2019 - 05/2015
2AcidsIBA
10/2018 - 11/2016
2GlucosidasesIBA
10/2018 - 11/2016
2SiliconIBA
06/2016 - 02/2016
2IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
05/2015 - 05/2006
2CamptothecinIBA
08/2012 - 02/2012
2Pharmaceutical PreparationsIBA
08/2012 - 02/2012
1Biological ProductsIBA
07/2020
1mannose-6-phosphateIBA
06/2016
1RutheniumIBA
02/2016
1LigandsIBA
02/2016
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2016
1LectinsIBA
05/2015
1Mannose ReceptorIBA
12/2014
1CarbohydratesIBA
08/2012
1galactose receptorIBA
02/2012
1Galactose (Galactopyranose)FDA LinkGeneric
02/2012
1Volatile Oils (Essential Oils)IBA
03/2011
1Pheromones (Semiochemicals)IBA
03/2011
1Phosphates (Orthophosphate)IBA
05/2006
1Transforming Growth Factor beta (TGF-beta)IBA
05/2006
1ProdrugsIBA
10/2003
1sparfosic acid (PALA)IBA
10/2003

Therapy/Procedure

9Photochemotherapy (Photodynamic Therapy)
10/2019 - 11/2011
4Therapeutics
10/2018 - 02/2012
3Precision Medicine
07/2020 - 05/2015
1Lasers (Laser)
10/2019
1Enzyme Therapy
01/2019
1Enzyme Replacement Therapy
10/2018